Kali PE Ratio Insights

Kali, Inc. (KALY)

0.0000 0.00 (0.00%) USD | OTCM | Aug 24, 16:00

PE Ratio Chart

View PE Ratio for KALY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View PE Ratio Chart

Start Trial

Historical PE Ratio Data

View and export this data back to 2009. Start Trial.

Date	Value
March 28, 2014	0.3286
March 27, 2014	0.3286
March 26, 2014	0.3286
March 25, 2014	0.3286
March 24, 2014	0.3286
March 21, 2014	0.3286
March 20, 2014	0.3286
March 19, 2014	0.3286
March 18, 2014	0.3286
March 17, 2014	0.3286
March 14, 2014	0.3286
March 13, 2014	0.3286
March 12, 2014	0.3286
March 11, 2014	0.3286
March 10, 2014	0.3286
March 07, 2014	0.3286
March 06, 2014	0.3286
March 05, 2014	0.3286
March 04, 2014	0.3286
March 03, 2014	0.3286
February 28, 2014	0.3286
February 27, 2014	0.3286
February 26, 2014	0.3286
February 25, 2014	0.2817
February 24, 2014	0.2653

Date	Value
February 21, 2014	0.2653
February 20, 2014	0.2653
February 19, 2014	0.2653
February 18, 2014	0.2653
February 14, 2014	0.2653
February 13, 2014	0.2653
February 12, 2014	0.2653
February 11, 2014	0.2653
February 10, 2014	0.3286
February 07, 2014	0.3286
February 06, 2014	0.3286
February 05, 2014	0.3286
February 04, 2014	0.3286
February 03, 2014	0.3286
January 31, 2014	0.3286
January 30, 2014	0.3286
January 29, 2014	0.3286
January 28, 2014	0.3286
January 27, 2014	0.3286
January 24, 2014	0.3286
January 23, 2014	0.338
January 22, 2014	0.3286
January 21, 2014	0.3286
January 17, 2014	0.3286
January 16, 2014	0.3521

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

View PE Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

PE Ratio Benchmarks

View PE Ratio Benchmarks

Start Trial

Sienna Biopharmaceuticals, Inc.	--
Acura Pharmaceuticals, Inc.	--
Virpax Pharmaceuticals, Inc.	--
Rising Biosciences, Inc.	--
Real Brands, Inc.	--

PE Ratio Related Metrics

Price	0.0000
Market Cap	0.001M